Health: EpiPen maker accused of overcharging for asthma drug
May 12, 2017 at 10:23 AM EDT
Heather Bresch, chief executive officer of Mylan NV, holds up an EpiPen while speaking during a House Oversight and Government Reform Committee hearing in 2016.
